Ove Alexander Høgmoen Åstrand

Years Active: 2019-2020
Publications (10 Years): 2

AlgiPharma AS

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AlgiPharma AS Sep 1o 2019

Norway

R&D Project Manager :: Research and Development

Publications

Ørjan Samuelsen, Ove Alexander Høgmoen Åstrand, Christopher Fröhlich, Adam Heikal, Susann Skagseth, Trine Josefine Olsen Carlsen, Hanna Kirsti Schrøder Leiros, Annette Bayer, Christian Schnaars, Geir Kildahl-Andersen, Silje Lauksund, Sarah Finke, Sandra Huber, Tor Gjøen, Adriana Magalhaes Santos Andresen, Ole Andreas Løchen Økstad, Pål Rongved
ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo. Antimicrobial agents and chemotherapy 64 (6) (2020)
Geir Kildahl-Andersen, Christian Schnaars, Anthony Prandina, Sylvie Radix, Marc Le Borgne, Lars Petter Jordheim, Tor Gjøen, Adriana Magalhães Santos Andresen, Silje Lauksund, Christopher Fröhlich, Ørjan Samuelsen, Pål Rongved, Ove Alexander Høgmoen Åstrand
Synthesis and biological evaluation of zinc chelating compounds as metallo-β-lactamase inhibitors. MedChemComm 10 (4) (2019)

Ove Alexander Høgmoen Åstrand.css-eqlu8i{font-size:small;padding-left:4px;}